BRIDGEBIO ONCOLOGY THERAPEUT

Historical 13F Holders

Symbol
BBOT
CUSIP
107924102
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 107924102 since 12/18/2024, largest first.

Filer % of Class Filed
Helix Holdings II LLC 13D/A
22.6% 8/13/2025
Event 8/11/2025
Bihua Chen 13D/A
22.3% 7/6/2026
Event 7/1/2026
BridgeBio Pharma LLC 13D
17.5% 8/18/2025
Event 8/11/2025
James E. Flynn 13G
6.2% 8/18/2025
Event 8/11/2025
BC Global Opportunities IX LP 13G
5.5% 9/3/2025
Event 9/4/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Citadel Advisors LLC 13G/A
3.2% 11/14/2025
Event 9/30/2025
Adage Capital Management, L.P. 13G/A
1.9% 11/13/2025
Event 9/30/2025
Price T Rowe Associates Inc /MD/ 13G 1.1% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 17 8.47 M $34.7M
2026 Q2 65 59.1 M $451M
2026 Q1 67 57.5 M $514M
2025 Q4 52 57.9 M $725M
2025 Q3 42 56.8 M $658M